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Abstract: The hemodialysis procedure is thought to be a physical stressor in the majority of hemodialyzed patients. Previous 
studies suggest that elevated salivary amylase level may correlate with increased plasma norepinephrine level under 
psychological and physical stress conditions. In this study, we investigated biological stress reactivity during hemodialysis 
treatment using salivary amylase activity as a biomarker. Seven patients (male/female = 5/2, age:67.7+/−5.9 years) who had 
been receiving regular 4 h hemodialysis were recruited. Salivary amylase activity was measured using a portable analyzer 
every hour during the hemodialysis session. Salivary amylase activity was shown to be relatively stable and constant 
throughout hemodialysis, whereas there were signiﬁ  cant changes in systolic blood pressure and pulse rate associated with 
blood volume reduction. Our results show that hemodialysis treatment per se dose not affect salivary amylase activity.
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Since stress reaction is a biological reaction caused by stress-induced alterations in the autonomic 
nervous system and endocrinological and immunological functioning, the complexity of this relation-
ship has not been fully elucidated. It is of interest to let us know how a person feels own condition 
somehow or other. There have been many attempts to quantify stress by various methods, including 
psychological tests and measurements of hormonal, cardiovascular responses and other physiological 
parameters. On really quantifying stress, it is a delicate problem to apply which indicator can do better 
that in a lot of indicators associated with stress. There are several indicators that are associated with 
stress and can be measured easily and economically. Recently, a portable salivary amylase activity 
analyzer has become available (Yamaguchi et al. 2004). Because salivary amylase is innerved by the 
sympathetic nervous system, it is expected that change in salivary amylase activity correlates well with 
stress (Chatterton et al. 1996). It has been suggested that salivary amylase activity is a useful index of 
plasma norepinephrine levels under a variety of stressful conditions, since it appears that increased 
sympathetic nervous activity is a major stimulator of amylase secretion (Skosnik et al. 2000). Not only 
psychological (Chatterton et al. 1997; Nater et al. 2006) but also physical stressors (Nexo et al. 1988; 
Steerenberg et al. 1997; Walsh et al. 1999; Skosnik et al. 2000) are able to stimulate salivary amylase 
activity. Saliva sampling is a noninvasive, painless, and convenient test modality.
Since ﬁ  rst successfully performed in 1945, hemodialysis (HD) has become a routine therapeutic 
procedure (Kolff, 2002). However, despite signiﬁ  cant improvements in HD equipment and improvement 
in patient monitoring, acute complications can still occur during the therapy. Intradialytic hypotension 
requiring medical intervention occurs in 10% to 30% of HD treatments (Levin et al. 1990). During 
volume removal by ultraﬁ  ltration, a reduced plasma reﬁ  lling rate coupled with impaired compensatory 
physiologic responses to hypovolemia may contribute to the pathogenesis of intradialytic hypotension 
(Liangos et al. 2005). On-line blood volume monitoring techniques have been used to control intradia-
lytic hypotensive episodes, but their effectiveness is controversial. Although occasionally asymptomatic, 
patients with hypotension may suffer from various symptoms including light-headedness, muscle cramps 
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and nausea. Besides, HD patients must also endure 
the pain from stabs with injection needles in HD 
sessions. The HD procedure is thought to be a 
physical stressor in the majority of hemodialyzed 
patient. We speculated that the HD procedure is a 
stressor and leads to enhanced salivary amylase 
activity with progress of the procedure. Thus, in 
the present study, we investigated the biological 
stress reactivity using salivary amylase activity as 
a biomarker. A portable salivary amylase activity 
analyzer was tested during the HD session.
Materials and Methods
Outpatients with stable disease conditions who had 
been treated with ordinary chronic regular HD for 
1 year or longer were enrolled in this study. Only 
outpatients aged 55 years or more were recruited 
for this study because there might be a difference 
in the reactiveness of salivary amylase activity in 
young subjects and aged subjects (Meyer et al. 
1940; Arglebe, 1979; Zhang, 1984; Ben-Aryeh, 
1986; Salvolini, 1999). All of the patients were 
dialyzed three times a week for 4 h each time. We 
excluded patients treated with any drug that may 
have contributed to action of the sympathetic ner-
vous system, such as alpha blockers, beta blockers 
(Nederfors et al. 1994; van Stegeren et al. 2006), 
alpha-methyldopa, etilefrine hydrochloride, 
amezinium metilsulfate, midodrine hydrochloride, 
L-threo-3, 4-dihidroxyphenylserine, and antide-
pressants (Koller et al. 2001). The study was con-
ducted in accordance with the declaration of 
Helsinki. A full explanation of the study, focusing 
on the purpose of the study and the precise proce-
dures, was given to all of the patients before enroll-
ment. Informed consent to participate in this study 
was obtained from each patient.
Salivary amylase activity was measured using a 
hand-held salivary amylase monitor manufactured 
by Nipro (Osaka, Japan). This analyzer enables 
automatic measurement of salivary amylase activity, 
using a dry-chemical system, within 1 min from 
collection to completion of the measurement 
(Yamaguchi et al. 2004; Yamaguchi et al. 2006b). 
The tip of the testing strip was soaked in a buffer 
containing Gal-G2-CNP (2-chloro-4-nitrophenyl-
4-O-beta-D-galactopyranosylmaltoside), which acts 
as a substrate, and chromogen and was then dried. 
The deﬁ  nition of one unit activity (U) per mass of 
enzyme (Yamaguchi et al. 2004) is that this activity 
produces 1 micro mol of the reducing sugar maltose 
in 1 min. The tip of the testing strip was set under 
the tongue for 30 sec to collect saliva. Then, the 
testing strip was immediated inserted into the ana-
lyzer, and the result was displayed automatically. 
The ﬁ  rst sample was measured as baseline salivary 
amylase activity, before vein cannulation. After 
vein cannulation, additional samples were obtained 
at 1-h intervals throughout the HD session, until 
the needle was removed after completion of HD. 
Subjects lay on a bed when samples were collected. 
Continuous monitoring of % blood volume 
reduction was performed using CRIT-LINE III 
(Hemametrics, Salt Lake City, UT, U.S.A.) during 
the HD session. Since it has been suggested that 
amylase activity have a diurnal behavior (Artino 
et al. 1998; Nater et al. 2007), the HD session was 
performed between 9:00 and 13:00 h, during which 
time patients did not have lunch.
Changes in salivary amylase activity, systolic 
blood pressure, pulse rate, and % blood volume 
reduction were analyzed using one-way repeated 
measures analysis of variance. Statistical 
signiﬁ  cance was deﬁ  ned at the level of p  0.05. 
Data are given as means and standard deviations. 
In ﬁ  gures, box and whisker plots indicate median 
value with interquartile range and 10%–90% 
range in the panel. Since salivary amylase 
activity showed variations in individuals, all of 
the measured amylase activity values were 
converted into logarithmic values (Yamaguchi 
et al. 2006a).
Results
The participants in this study included 5 men 
and 2 women. The mean age of the participants 
was 67.7 (SD = 5.9, range 58–76) years, and the 
mean duration of dialysis was 84.0 (SD = 59.1, 
range 14–188) months. Their primary renal 
diseases were chronic glomerulonephritis in 
5 cases and diabetic nephropathy in 2 cases. The 
mean value of salivary amylase activity at 
the baseline condition was 17.7 (SD = 17.4, 
range 2–49) kU/L. The mean ultrafiltration 
volume (removal of ﬂ  uid) during HD was 2.4 
(SD = 0.7, range 1.1–3.1) L. Blood volume 
decreased steadily throughout the HD session 
(p  0.0001) (Fig. 1).
Time courses of systolic blood pressure and 
pulse rate showed signiﬁ  cant patterns of change, 
as can be seen in Figure 2. HD resulted in a 
signiﬁ  cant decrease in systolic blood pressure with 431
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a trough at 2 h after the start of HD (p = 0.0011). 
Pulse rate decreased for the ﬁ  rst hour after the start 
of HD and thereafter continued to increase 
gradually (p = 0.0003).
From the pre-cannulation to the completion of 
HD, salivary amylase activity was shown to be 
relatively constant and was not signiﬁ  cantly dif-
ferent (Fig. 3). None of the patients complained of 
symptoms such as light-headedness, muscle 
cramps, nausea, cold sweat, dyspnea, chest pain, 
and fainting.
Discussion
Salivary amylase activity response is thought to 
be sensitive to psychological stressors, such as 
parachuting or skydiving anticipatory coping 
stress (Chatterton et al. 1997), passive watching 
of a gruesome video and psychosocial examina-
tion (Bosch et al. 2003; Rohleder et al. 2004), 
and to physical stressors, such as running, 
intensive exercise, and exposure to heat and 
cold (Chatterton et al. 1996). In a series of studies 
in which subjects were exposed to physical and 
psychological stressors, signiﬁ  cant correlations 
between salivary amylase activity and plasma 
norepinephrine were found. Nater et al. (2006) 
reported that general salivary amylase responses 
were associated with sympathetic tones, but not 
associated with general salivary cortisol responses, 
during stress conditions in a psychosocial exam-
ination. Using these results as support for the 
validity of measuring salivary amylase instead of 
catecholamine, several studies in which salivary 
amylase activity was measured as an indicator 
for norepinephrine were performed (Chatterton 
et al. 1996; Chatterton et al. 1997; Skosnik et al. 
2000; Nater et al. 2006). In this study, we exam-
ined the inﬂ  uence of the HD procedure on sali-
vary amylase activity in patients on HD. While 
there were signiﬁ  cant changes in systolic blood 
pressure and pulse rate associated with blood 
volume reduction during HD, salivary amylase 
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Figure 1. Change in % blood volume reduction during hemodialysis. Blood volume signiﬁ  cantly (p  0.0001) decreased steadily throughout 
hemodialysis. Box and whisker plots indicate median value with interquartile range and 10%–90% range.432
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Figure 2. Changes in systolic blood pressure and pulse rate during hemodialysis. A signiﬁ  cant decrease in systolic blood pressure (p = 0.0011) 
with a trough at 2 h after the start of hemodialysis was observed. Pulse rate signiﬁ  cantly (p = 0.0003) decreased for the ﬁ  rst hour after the 
start of hemodialysis and thereafter continued to increase gradually. Box and whisker plots indicate median value with interquartile range 
and 10%–90% range.
activity showed no difference during HD. The 
patients in this study did not show excess 
intradialytic hypotension causing discomfort, 
although they showed signiﬁ  cant falls in blood 
pressure. The occurrence of episodes of hypoten-
sion during HD treatments may contribute to 
stress reaction. However, symptomatic hypoten-
sion did not occur in the current study. Conse-
quently, it was unlikely that an increase in salivary 
amylase activity would be observed during 
routine HD treatment. Chicharro et al. (1998) 
reported that a saliva threshold exists during 
physical exercise. Routine HD treatment might 
have an effect on low stress intensity below the 
saliva threshold level. As the patients had been 
undergoing HD for a long time, they might have 
become accustomed to stresses of the HD 
procedure.
Results of studies regarding the relationship 
between salivary amylase activity and age are 
discrepant: results of studies have shown that 
salivary amylase activity declines with aging 
(Meyer et al. 1940; Ben-Aryeh, 1986), that 
salivary amylase activity does not differ with 433
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aging (Arglebe, 1979; Salvolini, 1999), and that 
salivary amylase activity is increased in the 
elderly (Zhang, 1984). Also, it is of interest to 
consider the possible inﬂ  uence of age in dialysis 
patients. Although the subjects in our study were 
elderly patients, the basal level of salivary amy-
lase activity was similar to that in a study by 
Yamaguchi et al. (2006a), who measured the basal 
salivary amylase activity in healthy young adults 
using a hand-held analyzer. 
The results of our study should be interpreted 
within the inherent limitations of the study. Our 
patient population was relatively small. Aged 
patients were enrolled in the current study, but 
young patients were not recruited in consideration 
of the possible inﬂ  uence of age. The relationship 
between salivary amylase activity and age is 
discrepant. Moreover, to achieve blood pressure 
control, most patients on HD would require mul-
tiple antihypertensive agents, including alpha 
blocker, beta blocker and alpha-methyldopa, and 
sympathomimetic agents, including etile-
frine hydrochloride, amezinium metilsulfate, 
midodrine hydrochloride and L-threo-3, 
4-dihidroxyphenylserine, which might contribute 
to the action of the sympathetic nervous system. 
Thus, most of the patients in our hospital were 
excluded before enrollment by the exclusion 
criteria. If possible, a case-control study should 
be designed. However, our study was not con-
ducted as a case-control study. It is considered 
ethically problematic to perform HD in healthy 
subjects as controls. Therefore, we could not 
perform such a study design. Therefore, our 
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Figure 3. Change in salivary amylase activity during hemodialysis. Measured values were converted into logarithmic values. No signiﬁ  cant 
effect associated with salivary amylase activity throughout hemodialysis was observed. Box and whisker plots indicate median value with 
interquartile range and 10%–90% range.434
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results might not be applicable to other medicated 
patients mentioned above.
In summary, our results show that the routine 
HD procedure per se does not affect salivary amy-
lase activity in patients treated with chronic HD. 
However, changes in salivary amylase activity 
possibly reﬂ  ect autonomic changes. Salivary amy-
lase is thus part of a general psychobiological 
stress response, which makes salivary amylase a 
very interesting variable that can easily be 
obtained.
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